Founded in May 2017 and based in Baltimore, Maryland, USA, EagleImmune is at the forefront of cellular immunotherapy innovation. Under the leadership of CEO Ying MU, PhD, DABT, our mission is driven by the commitment to combat cancer by thoroughly identifying and eliminating multiple targets hidden within solid tumors.